Is ADMA Biologics, Inc. (ADMA) a Buy, Sell, or Hold?
ADMA Biologics, Inc.
NASDAQ:ADMA
$8.87 USD
-$0.1 (-1.11%)
- Volume
- 2.7M
- Average Volume
- 5.01M
- Market Capitalization
- $2.06B
- P/E Ratio
- 12.86
- Dividend Yield
- 0.00%
- Price Target
- $21.00
- Year High
- $20.46
- Year Low
- $7.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.95
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-57.8% DOWNSIDE
$21.00 Price Target
UPSIDE/DOWNSIDE HIGH
-63.0% DOWNSIDE
$24.00 Price Target High
UPSIDE/DOWNSIDE LOW
-50.7% DOWNSIDE
$18.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Ryan Deschner | $21 | $8.12 | 2026-06-10 07:25 AM | 158.6% |
| Canaccord Genuity | Gary Nachman | $18 | $10.08 | 2026-05-07 06:40 AM | 78.6% |
| Mizuho Securities | Anthony Petrone | $24 | $10.33 | 2026-04-13 10:35 AM | 132.3% |
| H.C. Wainwright | Raghuram Selvaraju | $18 | $17.145 | 2024-10-14 02:58 AM | 5.0% |
| Mizuho Securities | Anthony Petrone | $14 | $10.62 | 2024-06-20 02:47 AM | 31.8% |